Scientists use scans to watch TB drug travel through patients
NCT ID NCT05609552
Summary
This small study aimed to understand how a tuberculosis drug, pretomanid, moves through and concentrates in the bodies of patients. Researchers used a special PET scan to track a tiny, safe amount of a radioactive version of the drug in 10 people with TB. The goal was to see if the drug reaches infected lung areas effectively, which could help improve future TB treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Medical Institutions
Baltimore, Maryland, 21218, United States
Conditions
Explore the condition pages connected to this study.